BR0301547C1 - composição farmacêutica para tratar patologia fúngica compreendendo lectina km+, composição farmacêutica para prevenir patologia fúngica compreendendo lectina km+, uso de lectina km+ para preparar medicamento para tratar patologia fúngica, uso de lectina km+ para preparar medicamento para prevenir patologia fúngica - Google Patents

composição farmacêutica para tratar patologia fúngica compreendendo lectina km+, composição farmacêutica para prevenir patologia fúngica compreendendo lectina km+, uso de lectina km+ para preparar medicamento para tratar patologia fúngica, uso de lectina km+ para preparar medicamento para prevenir patologia fúngica

Info

Publication number
BR0301547C1
BR0301547C1 BRC10301547-5A BR0301547A BR0301547C1 BR 0301547 C1 BR0301547 C1 BR 0301547C1 BR 0301547 A BR0301547 A BR 0301547A BR 0301547 C1 BR0301547 C1 BR 0301547C1
Authority
BR
Brazil
Prior art keywords
lectin
pathology
pharmaceutical composition
fungal pathology
preparing medicine
Prior art date
Application number
BRC10301547-5A
Other languages
English (en)
Other versions
BR0301547A (pt
Inventor
Maria Cristina Roque Barreira
Ademilson Panunto Castelo
Maria Helena De Souza Goldman
Luis Lamberti Pinto Da Silva
Ricardo Santos De Oliveira
Marcelo Dias Baruffi
Jeanne Blanco De Molfe Machado
Original Assignee
Fundacao De Amparo A Pesquisa
Univ Sao Paulo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fundacao De Amparo A Pesquisa, Univ Sao Paulo filed Critical Fundacao De Amparo A Pesquisa
Priority to BRC10301547-5A priority Critical patent/BR0301547C1/pt
Priority to ARP040101722A priority patent/AR044389A1/es
Priority to EP04733749A priority patent/EP1635891A2/en
Priority to JP2006529469A priority patent/JP2007528869A/ja
Priority to PCT/BR2004/000070 priority patent/WO2004100861A2/en
Publication of BR0301547A publication Critical patent/BR0301547A/pt
Publication of BR0301547C1 publication Critical patent/BR0301547C1/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C07K14/42Lectins, e.g. concanavalin, phytohaemagglutinin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dermatology (AREA)
  • Botany (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

"COMPOSIçãO FARMACêUTICA PARA TRATAR PATOLOGIA FúNGICA COMPREENDENDO LECTINA KM+, COMPOSIçãO FARMACêUTICA PARA PREVENIR PATOLOGIA FúNGICA COMPREENDENDO LECTINA KM+, USO DE LECTINA KM+ PARA PREPARAR MEDICAMENTO PARA TRATAR PATOLOGIA FúNGICA, USO DE LECTINA KM+ PARA PREPARAR MEDICAMENTO PARA PREVENIR PATOLOGIA FúNGICA". A presente invenção trata de composição farmacêutica para tratar patologia fúngica compreendendo lectina KM+. A invenção compreende, também, o uso de lectina KM+ para preparar medicamento para tratar patologia fúngica.
BRC10301547-5A 2003-05-19 2003-05-19 composição farmacêutica para tratar patologia fúngica compreendendo lectina km+, composição farmacêutica para prevenir patologia fúngica compreendendo lectina km+, uso de lectina km+ para preparar medicamento para tratar patologia fúngica, uso de lectina km+ para preparar medicamento para prevenir patologia fúngica BR0301547C1 (pt)

Priority Applications (5)

Application Number Priority Date Filing Date Title
BRC10301547-5A BR0301547C1 (pt) 2003-05-19 2003-05-19 composição farmacêutica para tratar patologia fúngica compreendendo lectina km+, composição farmacêutica para prevenir patologia fúngica compreendendo lectina km+, uso de lectina km+ para preparar medicamento para tratar patologia fúngica, uso de lectina km+ para preparar medicamento para prevenir patologia fúngica
ARP040101722A AR044389A1 (es) 2003-05-19 2004-05-18 Composicion farmaceutica que comprende lectina km+
EP04733749A EP1635891A2 (en) 2003-05-19 2004-05-19 Pharmaceutical composition to prevent and treat epithelial wounds, immunomodulating pharmaceutical composition, pharmaceutical composition, insecticide, insecticide composition, insecticide use of lectin km+ to treat cicatrizations, use of lectin km+ to prepare immunomodulating medicament
JP2006529469A JP2007528869A (ja) 2003-05-19 2004-05-19 上皮創傷予防・治療用医薬組成物、免疫調節性医薬組成物、医薬組成物、殺虫剤、殺虫剤組成物、瘢痕化治療におけるレクチンkm+の殺虫剤使用、免疫調節性薬剤調合におけるレクチンkm+の使用、抗菌薬剤調合におけるレクチンkm+の使用、抗ウイルス剤調合におけるレクチンkm+の使用、抗真菌薬調合におけるレクチンkm+の使用、抗寄生虫薬調合におけるレクチンkm+の使用、発現方法、dnaベクター、組換え有機体、ヌクレオチド配列、抗体、プロテイン及び核外遺伝子
PCT/BR2004/000070 WO2004100861A2 (en) 2003-05-19 2004-05-19 Pharmaceutical composition comprising lectin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRC10301547-5A BR0301547C1 (pt) 2003-05-19 2003-05-19 composição farmacêutica para tratar patologia fúngica compreendendo lectina km+, composição farmacêutica para prevenir patologia fúngica compreendendo lectina km+, uso de lectina km+ para preparar medicamento para tratar patologia fúngica, uso de lectina km+ para preparar medicamento para prevenir patologia fúngica

Publications (2)

Publication Number Publication Date
BR0301547A BR0301547A (pt) 2005-03-22
BR0301547C1 true BR0301547C1 (pt) 2007-02-21

Family

ID=37744501

Family Applications (1)

Application Number Title Priority Date Filing Date
BRC10301547-5A BR0301547C1 (pt) 2003-05-19 2003-05-19 composição farmacêutica para tratar patologia fúngica compreendendo lectina km+, composição farmacêutica para prevenir patologia fúngica compreendendo lectina km+, uso de lectina km+ para preparar medicamento para tratar patologia fúngica, uso de lectina km+ para preparar medicamento para prevenir patologia fúngica

Country Status (5)

Country Link
EP (1) EP1635891A2 (pt)
JP (1) JP2007528869A (pt)
AR (1) AR044389A1 (pt)
BR (1) BR0301547C1 (pt)
WO (1) WO2004100861A2 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2914858B1 (fr) * 2007-04-13 2012-09-21 Lucas Meyer Cosmetics Composition cosmetique

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020001600A1 (en) * 1995-05-30 2002-01-03 Michael J. Oldham Method of using lectins for prevention and treatment of skin diseases and disorders

Also Published As

Publication number Publication date
EP1635891A2 (en) 2006-03-22
AR044389A1 (es) 2005-09-07
WO2004100861A3 (en) 2006-12-07
WO2004100861A2 (en) 2004-11-25
JP2007528869A (ja) 2007-10-18
BR0301547A (pt) 2005-03-22

Similar Documents

Publication Publication Date Title
BRPI0618239A8 (pt) uso de flibanserina para o tratamento de distúrbios de desejo sexual pré-menopáusicos
UA96449C2 (en) Stable laquinimod preparations
BR0213358A (pt) Uso de flibanserina
AR023574A1 (es) Compuestos de azepinindol tetraciclico,composiciones farmaceuticas y el uso de dichos compuestos para preparar un medicamento, e intermediarios
WO2006099169A3 (en) Novel liposome compositions
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
BRPI0409133A (pt) formulações farmacêuticas contendo metilnaltrexona
HK1084941A1 (en) Compounds and their use
EA200901393A1 (ru) Фармацевтическая композиция, содержащая гестагены и/или эстрогены и 5 метил-(6s)-тетрагидрофолат
GT200600258A (es) Derivados de n-(piridin-2-il)-sulfonamida
BRPI0608853B8 (pt) composições farmacêuticas e processo para a fabricação de microgrânulos de rifaximina gastrorresistentes
BRPI0412893A (pt) composto, composição farmacêutica, uso de um composto, e, métodos de prevenção, tratamento ou melhora de doenças ou condições inflamatórias, ou doenças ou condições oftálmicas, de tratamento ou melhora de cáncer e para a produção de um composto
BRPI0418099A (pt) compostos, composição farmacêutica, e uso de um composto
BR0112589A (pt) Derivados de heteroarila e sua aplicação como medicamento
BR0210139A (pt) Composições farmacêuticas
PA8575601A1 (es) Procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso
TW200508197A (en) Indolone-acetamide derivatives, processes for preparing them and their uses
ECSP066663A (es) Composición farmacéutica de vinflunina para administración parenteral, proceso de preparación y su uso
TW200626581A (en) Compounds, compositions containing them, preparation thereof and uses thereof
ITMI20031396A1 (it) Composizione per uso farmaceutico o dietetico o cosmetico dotata di attivita' antiossidante.
BRPI0411702B8 (pt) uso de ácido hialurônico para preparar composições para o tratamento de aftas da cavidade oral
MXPA04001419A (es) Isoxazolopiridinonas y su uso en el tratamiento de enfermedad de parkinson.
TW200740440A (en) Novel combinations of medicaments for the treatment of respiratory diseases containing long-acting beta-agonists and at least one additional active ingredient
UY29561A1 (es) Derivados de quinazolina, composiciones farmacéuticas que los contienen, procedimientos de preparación y aplicaciones
TW200504051A (en) Novel acridine derivatives and their use as medicaments

Legal Events

Date Code Title Description
B25C Requirement related to requested transfer of rights

Owner name: FUNDACAO DE AMPARO A PESQUISA DO ESTADO DE SAO PAU

Free format text: A FIM DE ATENDER A TRANSFERENCIA SOLICITADA ATRAVES DA PETICAO NO 020187/SP DE 16/11/2004, REAPRESENTE O DOCUMENTO DE CESSAO COM O RECONHECIMENTO DA FIRMA DO CESSIONARIO.

B25L Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: publication cancelled

Owner name: FUNDACAO DE AMPARO A PESQUISA DO ESTADO DE SAO PAU

Free format text: REFERENTE A RPI 1859 DE 22/08/2006 COD. (25.3), POR TER SIDO INDEVIDO.

B25A Requested transfer of rights approved

Owner name: FUNDACAO DE AMPARO A PESQUISA DO ESTADO DE SAO PAU

Free format text: TRANSFERIDO PARTE DOS DIREITOS DE: FUNDACAO DE AMPARO A PESQUISA DO ESTADO DE SAO PAULO - FAPESP

B03A Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette]

Free format text: ADDITIONAL INVENTOR'S CERTIFICATE:

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B12C Appeal against dismissal [chapter 12.3 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: ADDITIONAL INVENTOR'S CERTIFICATE:

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]

Free format text: ADDITIONAL INVENTOR'S CERTIFICATE:

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: ADDITIONAL INVENTOR'S CERTIFICATE:

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL

B11Q Dismissal: the certificate of addition was not accessory to any patent, or a patent which was nominated accessory and no longer exists

Free format text: ADDITIONAL INVENTOR'S CERTIFICATE:

B11T Dismissal of application maintained [chapter 11.20 patent gazette]

Free format text: ADDITIONAL INVENTOR'S CERTIFICATE: